Future studies should focus on examining the tumor microenvironment, immune responses, and molecular pathways unique to stage II HNSCC, as well as exploring potential genetic and epigenetic differences that may regulate PIGF expression. Here, PIGF is linked to head and neck squamous cell carcinoma.